Bliss GVS Pharma Limited has informed the Exchange about Copy of the Newspaper Publication regarding the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2025.
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bliss GVS Pharma has submitted copies of newspaper advertisements publishing its audited standalone and consolidated financial results for the quarter and year ended March 31, 2025. The results were approved by the Board of Directors at a meeting held on May 12, 2025. The advertisements were published on May 14, 2025 in The Economic Times and The Free Press Journal (English dailies) and Maharashtra Times and Navshakti (regional/Marathi dailies), in compliance with SEBI Regulation 47. The notice includes a QR code and weblink to the company's website for accessing the full financial results.
This is a routine regulatory compliance filing and does not contain any new financial information. The actual results numbers would have been disclosed separately when approved by the Board on May 12, 2025. No immediate stock price impact expected from this specific filing.